Wells Fargo’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
158,683
+49,861
| +46% | +$97.2K | ﹤0.01% | 4106 |
|
|
2025
Q1 | $192K | Buy |
108,822
+2,406
| +2% | +$4.24K | ﹤0.01% | 4297 |
|
|
2024
Q4 | $283K | Buy |
106,416
+23,178
| +28% | +$61.7K | ﹤0.01% | 4093 |
|
|
2024
Q3 | $191K | Buy |
83,238
+4,249
| +5% | +$9.73K | ﹤0.01% | 4223 |
|
|
2024
Q2 | $231K | Buy |
78,989
+27,506
| +53% | +$80.3K | ﹤0.01% | 4074 |
|
|
2024
Q1 | $187K | Buy |
51,483
+6,612
| +15% | +$24.1K | ﹤0.01% | 4146 |
|
|
2023
Q4 | $67.8K | Buy |
44,871
+8,858
| +25% | +$13.4K | ﹤0.01% | 4725 |
|
|
2023
Q3 | $48.3K | Sell |
36,013
-19,428
| -35% | -$26K | ﹤0.01% | 4844 |
|
|
2023
Q2 | $99.8K | Buy |
55,441
+34,603
| +166% | +$62.3K | ﹤0.01% | 4772 |
|
|
2023
Q1 | $34.6K | Buy |
+20,838
| New | +$34.6K | ﹤0.01% | 5068 |
|
|
2022
Q4 | – | Sell |
-442
| Closed | -$1K | – | 7278 |
|
|
2022
Q3 | $1K | Sell |
442
-1,029
| -70% | -$2.33K | ﹤0.01% | 6078 |
|
|
2022
Q2 | $5K | Sell |
1,471
-82,331
| -98% | -$280K | ﹤0.01% | 5714 |
|
|
2022
Q1 | $441K | Sell |
83,802
-52,953
| -39% | -$279K | ﹤0.01% | 4226 |
|
|
2021
Q4 | $1.16M | Buy |
136,755
+35,441
| +35% | +$301K | ﹤0.01% | 3746 |
|
|
2021
Q3 | $1.01M | Buy |
101,314
+48,114
| +90% | +$479K | ﹤0.01% | 4004 |
|
|
2021
Q2 | $496K | Buy |
53,200
+51,093
| +2,425% | +$476K | ﹤0.01% | 4343 |
|
|
2021
Q1 | $22K | Buy |
+2,107
| New | +$22K | ﹤0.01% | 5759 |
|